These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10314101)

  • 21. A review of cost-benefit and cost-effectiveness analyses of clinical pharmacy services.
    MacKeigan LD; Bootman JL
    J Pharm Mark Manage; 1988; 2(3):63-84. PubMed ID: 10312728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversification strategies for hospital pharmacies.
    Smith JE; Phillips DJ; Meyer GE
    Am J Hosp Pharm; 1984 Sep; 41(9):1788-91. PubMed ID: 6496513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reimbursement dilemma regarding home health-care products and services.
    Curtiss FR
    Am J Hosp Pharm; 1984 Aug; 41(8):1548-57. PubMed ID: 6433706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving provider support of pharmacy benefit design.
    Navarro RP
    Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacist's role in home i.v. therapy.
    McAllister JC
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S10-4. PubMed ID: 2505613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and misuse of pharmacoeconomic terms: a definitions primer.
    Sanchez LA; Lee J
    Top Hosp Pharm Manage; 1994 Jan; 13(4):11-22. PubMed ID: 10184005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacists can ensure quality at acceptable costs.
    Skaar DJ; Oki JC; Elenbaas RM
    Healthc Financ Manage; 1991 Dec; 45(12):90, 92. PubMed ID: 10145551
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacoeconomic principles and methods: including pharmacoeconomics into hospital pharmacy practice.
    Sanchez LA
    Hosp Pharm; 1994 Nov; 29(11):1035-6, 1039-40. PubMed ID: 10138578
    [No Abstract]   [Full Text] [Related]  

  • 30. Some evidence of the cost-effectiveness of home care.
    Cabin W
    Caring; 1985 Oct; 4(10):62-7, 70. PubMed ID: 10311301
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effective pharmacy services.
    Bishop SA
    Top Health Care Financ; 1980; 6(4):75-84. PubMed ID: 6775388
    [No Abstract]   [Full Text] [Related]  

  • 32. Revenue enhancement and cost analysis.
    Suver JD; Cooper JC
    Healthc Exec; 1994; 9(4):41. PubMed ID: 10135158
    [No Abstract]   [Full Text] [Related]  

  • 33. Perspective: making a pharmacy residency program cost effective.
    Ezaki LS
    Curr Concepts Hosp Pharm Manage; 1988; 10(3):5-7. PubMed ID: 10312576
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospectus on the economic value of clinical pharmacy services. A position statement of the American College of Clinical Pharmacy.
    Willett MS; Bertch KE; Rich DS; Ereshefsky L
    Pharmacotherapy; 1989; 9(1):45-56. PubMed ID: 2493639
    [No Abstract]   [Full Text] [Related]  

  • 35. Case studies of pharmacy involvement in hospital-based home health care. Good Samaritan Hospital & Medical center.
    Egging PK; Slotfeldt ML
    Am J Hosp Pharm; 1986 Feb; 43(2):396-401. PubMed ID: 3082198
    [No Abstract]   [Full Text] [Related]  

  • 36. The cost-effectiveness of home care.
    Caring; 1986 Aug; 5(8):27-9. PubMed ID: 10311660
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effective potential for home health care.
    Eastaugh SR
    Manag Care Q; 2001; 9(1):41-4. PubMed ID: 11252394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economics of hospital pharmacy practice. I. Third-party reimbursement.
    Zellmer WA
    Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204
    [No Abstract]   [Full Text] [Related]  

  • 39. Determining the differences among cost savings, cost avoidance, and cost reduction.
    Howard KB; Pathak DS
    Pharm Pract Manag Q; 1999 Oct; 19(3):1-7. PubMed ID: 10747680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions.
    Soumerai SB; Avorn J
    Milbank Mem Fund Q Health Soc; 1984; 62(3):447-74. PubMed ID: 6433223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.